CCR5 in urothelial cancer Excerpt: Conclusions: We show, for the first time, a high expression of CCR5 in the tissue of urothelial carcinoma using an assay based on a safe and effective receptor inhibitor. Our findings may have therapeutic implications if validated in more extensive studies. Used PRO 140 as assay.

https://esmed.org/MRA/mra/article/view/4620